Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

HHS scientist discovers cartilage formation stimulant

July 5, 1996

Kyowa Hakko isolates antitumor/antibacterial compound from Streptomyces

July 5, 1996

Johns Hopkins researches HIC-1-associated tumor

July 5, 1996

Zeneca reveals antiproliferative aniline derivatives

July 5, 1996

Halistatin 3: Antineoplastic agent of marine origin

July 5, 1996

Cytotoxic compound eleutherobin reported by University of California

July 5, 1996

Glaxo Wellcome describes antitumor antibody conjugates

July 5, 1996

Antitumor vaccines described by University of Pennsylvania

July 5, 1996

Human Genome Sciences reports discovery of TNF-gamma

July 5, 1996

Pharmacia & Upjohn reports taxane derivatives

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...